Client & Alumni News

Micro Interventional Devices Completes STASIS Clinical Trial Enrollment

Micro Interventional Devices, Inc. has completed enrollment in its Secure Transapical Access and Closure Study (STASIS). STASIS is a CE-Mark study that evaluates the safety and performance of the company’s Permaseal™, the world’s first automated direct myocardial ventricular access and closure technology especially designed for use in certain heart procedures. Read more: